Rates and risk factors for recurrence of hepatocellular carcinoma after initial complete remission in response to transcatheter arterial chemoembolization: A systematic review and meta-analysis. This ...
Phase II Trial of Enfortumab Vedotin in Patients With Previously Treated Advanced Head and Neck Cancer Liver transplantation (LT) has been accepted as a cornerstone of care in hepatocellular carcinoma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results